HCA Healthcare (NYSE: HCA) SVP Rossitto details stock, RSUs and SARs holdings

Rhea-AI Filing Summary

HCA Healthcare, Inc. senior vice president and Chief Nurse Executive Erica Rossitto reported her equity holdings as an officer of the company. She directly owns 9,149 shares of HCA common stock, along with restricted stock units covering 105 and 323 shares that convert into common stock as they vest beginning January 31, 2027. She also holds multiple stock appreciation rights grants over various share amounts, with exercise prices ranging from $81.96 to $482.53 and expiration dates between 2027 and 2036, many of which vest in four equal annual installments starting from specific past and future dates.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rossitto Erica

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2026

3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Nurse Executive

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	9,149	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	01/30/2027	01/30/2033	Common Stock	105	(1)	D
Restricted Stock Units	(2)	01/31/2034	Common Stock	323	(1)	D
Stock Appreciation Right	(3)	02/01/2027	Common Stock	8,080	$81.96	D
Stock Appreciation Right	(4)	01/31/2028	Common Stock	5,040	$101.16	D
Stock Appreciation Right	(5)	01/30/2029	Common Stock	3,230	$139.06	D
Stock Appreciation Right	(6)	01/29/2030	Common Stock	1,670	$145.24	D
Stock Appreciation Right	(7)	10/27/2030	Common Stock	960	$130.56	D
Stock Appreciation Right	(8)	02/03/2031	Common Stock	1,840	$173.12	D
Stock Appreciation Right	(9)	01/28/2032	Common Stock	1,390	$236.61	D
Stock Appreciation Right	(10)	01/30/2033	Common Stock	1,263	$253.3	D
Stock Appreciation Right	(11)	01/31/2034	Common Stock	1,859	$304.9	D
Stock Appreciation Right	(12)	01/28/2035	Common Stock	2,235	$328.7	D
Stock Appreciation Right	(13)	01/29/2036	Common Stock	2,560	$482.53	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.

2. The restricted stock units vest in two equal annual installments beginning on January 31, 2027.

3. The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

4. The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

5. The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

6. The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.

7. The stock appreciation rights vested in four equal annual installments beginning on October 27, 2021.

8. The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.

9. The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023.

10. The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.

11. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

12. The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

13. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

	/s/ Kevin A. Ball, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the HCA (HCA) Form 3 filing for Erica Rossitto show?

The Form 3 shows that HCA Healthcare SVP & Chief Nurse Executive Erica Rossitto beneficially owns 9,149 common shares, restricted stock units for 105 and 323 shares, and multiple stock appreciation rights grants with varying exercise prices and expirations, reflecting her existing equity-based compensation position.

How many HCA Healthcare (HCA) common shares does Erica Rossitto directly own?

Erica Rossitto directly owns 9,149 shares of HCA Healthcare common stock. This direct ownership is reported in Table I of the filing as beneficially owned common stock, separate from her restricted stock units and stock appreciation rights listed in the derivative securities table.

What restricted stock units does HCA executive Erica Rossitto hold?

Erica Rossitto holds two blocks of restricted stock units, covering 105 and 323 HCA common shares. Each unit represents a contingent right to receive one share, with these awards scheduled to vest in two equal annual installments beginning on January 31, 2027, subject to applicable vesting conditions.

What stock appreciation rights are reported for HCA (HCA) SVP Erica Rossitto?

Rossitto holds several stock appreciation rights grants over different share amounts, including 8,080 shares at an exercise price of $81.96 and additional grants with exercise prices up to $482.53. These grants have expiration dates from 2027 through 2036 and generally vest in four equal annual installments.

Is the HCA (HCA) Form 3 for Erica Rossitto a record of new stock transactions?

The Form 3 functions as an initial statement of beneficial ownership for Erica Rossitto as an HCA officer. It lists her existing common stock, restricted stock units, and stock appreciation rights positions, rather than disclosing new open-market purchases or sales of HCA Healthcare securities.